Member Info for Jacobjohn7

Risks

What could happen that would invalidate this narrative?

Changes in NIH funding and hospital budget constraints could lead to delayed purchase decisions and reduced capital spending by academic medical centers, impacting Polarean Imaging's revenue growth.

Polarean Imaging's cash burn rate and the need to raise additional capital before starting the gas exchange clinical trial present financial risks that could affect net margins and earnings.

The company's reliance on its sales team's current effectiveness may pose execution risks, potentially impacting revenue if commercial activities do not translate to expected sales growth.

International expansion efforts may face regulatory and market entry challenges, which could delay revenue growth outside the U.S. and affect overall earnings.

The high cost of conducting clinical trials, despite the expected reduction in costs, still presents financial risks that could impact profitability if not managed efficiently.

Cvj already put in the caveat that any traction might slip into next year.

And cost cutting across institutions not helping

Apologies required to those you hood winked here.

No hand holder for gas exchange.

3m left in kitty after gas exchange.

Dilution in the cross hairs

They looked after corporate and directors and absolutely caned the small investor.

Money ran dry as it is now with too many Indian chef directors speeding up the Demise without bringing anything to the table.

In essence a well fed under worked gravy train, a company with zero current year revenue and historical contemptible treatment of private investors is NOT a great company unless you spend your all day on magic mushrooms...

It's a company with impending 2025 forecast reduction and then focus on dilution.

Any advantage was lost by simply being too slow or mind and body.

Dyor. Good luck anyone trying to avoid this

As followers and holders than newbie space tom and his ai orating that generally makes little sense when you pick through the jargon.

No that all held the same deja vu pipedream of a big handholding partner, before money ran dry and th

Wait for those shares to be diluted, if they can manage a raise on no 2025 current logged revenue.

Forecast downgrade impending.

space tom been on the space dust...

modest sales... try none existence of sales for 12 whole months of an 18 month cash runway window.

without revenue = uninvestable maybe to the ******ed

*visible revenue

So presumably 7m cash runway now and no visible runway obtained this year. .

Not a great mix

The blinkered would be wise to focus on their 'investment' if you can call it that... money pit maybe rather than seeing a post by myself.

Revenue none existent but the deceitful here say 6-7 million 2025??

Nothing happening fast here. At least be some updates in the fy results.

But we've had nothing revenue based for nearly a full year now.

obviously time to evaluate here.

Not the tech, cvj hasn't done an hard day in his life.

6/7 mil for current year can't happen on current facts, it will currently be lot lower than 2024.. unless they started doing deals and not telling the market.

I really can't see 6/7 million current year... without any commercial news with pound notes quoted how can It possibly be?

We currently on just some consumables

Lots will happen in 2025, may is when I starts.

Just gets better .. gotta translate into increased adoption

https://www.linkedin.com/posts/polarean-inc-_xenonmri-pulmonaryhypertension-ph-activity-7318636449455636480-rmtA?utm_source=share&utm_medium=member_android&rcm=ACoAADdraCMBGzU5aJKAr453wDwlS2etY-tqE0c

Agree, a nicely reasoned synopsis and in agreement.

Thanks tom

I would add bracco making more and more appreciative noises. A strong constant backer, on the board, why? Seen it in medical tech many times. Board member fron large supportive shareholder, positioned for a highly likely bid imho.

Https://www.linkedin.com/posts/erinangel_pediatriccare-builtforkids-futureofhealthcare-activity-7316122109305360384-hG0h?utm_source=share&utm_medium=member_android&rcm=ACoAADdraCMBGzU5aJKAr453wDwlS2etY-tqE0c

Https://www.linkedin.com/posts/polarean-inc-_xenonmri-longcovid-lunghealth-activity-7315803447818113025-Y11D?utm_source=share&utm_medium=member_android&rcm=ACoAADdraCMBGzU5aJKAr453wDwlS2etY-tqE0c

thanks trump you horrible orange ****

Large rollover or amati finishing? If not already done so

At present sales and revenue required ... I'm sure they won't have no sales logged /timed for open budget season.

As thr tech offer has improved a lot this last year.

The news is pent up and ready to blow imho